Aspiration & Biopsy Needles Market by Product Type, Procedure, Applications, End-user

Description

List of Tables

[183 Pages Report] The Aspiration & Biopsy Needles Market size was estimated at USD 995.26 million in 2023 and expected to reach USD 1,077.35 million in 2024, at a CAGR 8.73% to reach USD 1,788.45 million by 2030.

Global Aspiration & Biopsy Needles Market

KEY MARKET STATISTICS
Base Year [2023]	USD 995.26 million
Estimated Year [2024]	USD 1,077.35 million
Forecast Year [2030]	USD 1,788.45 million
CAGR (%)	8.73%

Aspiration & Biopsy Needles Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aspiration & Biopsy Needles Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aspiration & Biopsy Needles Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aspiration & Biopsy Needles Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Becton, Dickinson and Company, Biomedical Srl, Boston Scientific Corporation, Cardinal Health, Inc., Conmed Corporation, Cook Group Incorporated, Doctor Japan Co., Ltd., Geotek Medical, Hakko Co., Ltd., Inrad, Inc., Iscon Surgicals Ltd., Medtronic, Plc, Merit Medical Systems, Inc., Mermaid Medical Group, Nemvelo Healthcare, Olympus Corporation, Ranfac Corp., Remington Medical Inc., Somatex Medical Technologies GmbH, Stryker Corporation, Suretech Medical Inc., Volkmann MedizinTechnik GmbH, and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Aspiration & Biopsy Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Aspiration Needles
- Biopsy Needles
  - Core Needle Biopsy
  - Vacuum-Assisted Biopsy Needles
Procedure
- Image-Guided Procedures
- Non Image-Guided Procedures
Applications
- Tumor/Cancer
- Wound
End-user
- Ambulatory Care Centers
- Diagnostic Clinics & Laboratories
- Hospitals & Surgical Centers
- Research & Academic Institutes
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aspiration & Biopsy Needles Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aspiration & Biopsy Needles Market?

3. What are the technology trends and regulatory frameworks in the Aspiration & Biopsy Needles Market?

4. What is the market share of the leading vendors in the Aspiration & Biopsy Needles Market?

5. Which modes and strategic moves are suitable for entering the Aspiration & Biopsy Needles Market?

Product Code: MRR-5A2C6AA66C23

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Aspiration & Biopsy Needles Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of cancer worldwide
  - 5.1.1.2. Rising cancer awareness initiatives and treatment centers
  - 5.1.1.3. Growing preferences for minimally invasive biopsies
- 5.1.2. Restraints
  - 5.1.2.1. Infection risk associated with the use of aspiration and biopsy needles
- 5.1.3. Opportunities
  - 5.1.3.1. Enhancement in the healthcare infrastructure for disease management techniques
  - 5.1.3.2. Favorable government's policies and insurance services
- 5.1.4. Challenges
  - 5.1.4.1. Diagnostic challenges in the fine-needle aspiration biopsy and problematic issues in breast core needle biopsies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Aspiration & Biopsy Needles Market, by Product Type

6.1. Introduction
6.2. Aspiration Needles
6.3. Biopsy Needles
- 6.4.1. Core Needle Biopsy
- 6.4.2. Vacuum-Assisted Biopsy Needles

7. Aspiration & Biopsy Needles Market, by Procedure

7.1. Introduction
7.2. Image-Guided Procedures
7.3. Non Image-Guided Procedures

8. Aspiration & Biopsy Needles Market, by Applications

8.1. Introduction
8.2. Tumor/Cancer
8.3. Wound

9. Aspiration & Biopsy Needles Market, by End-user

9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Diagnostic Clinics & Laboratories
9.4. Hospitals & Surgical Centers
9.5. Research & Academic Institutes

10. Americas Aspiration & Biopsy Needles Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Aspiration & Biopsy Needles Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Aspiration & Biopsy Needles Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Advin Health Care
- 14.1.2. Argon Medical Devices, Inc.
- 14.1.3. Becton, Dickinson and Company
- 14.1.4. Biomedical Srl
- 14.1.5. Boston Scientific Corporation
- 14.1.6. Cardinal Health, Inc.
- 14.1.7. Conmed Corporation
- 14.1.8. Cook Group Incorporated
- 14.1.9. Doctor Japan Co., Ltd.
- 14.1.10. Geotek Medical
- 14.1.11. Hakko Co., Ltd.
- 14.1.12. Inrad, Inc.
- 14.1.13. Iscon Surgicals Ltd.
- 14.1.14. Medtronic, Plc
- 14.1.15. Merit Medical Systems, Inc.
- 14.1.16. Mermaid Medical Group
- 14.1.17. Nemvelo Healthcare
- 14.1.18. Olympus Corporation
- 14.1.19. Ranfac Corp.
- 14.1.20. Remington Medical Inc.
- 14.1.21. Somatex Medical Technologies GmbH
- 14.1.22. Stryker Corporation
- 14.1.23. Suretech Medical Inc.
- 14.1.24. Volkmann MedizinTechnik GmbH
- 14.1.25. Zamar Care
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing